Pieris Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -0.0816 | -100% |
| P/S |
|
0.3316 | 33.76 | -99.02% |
|
|
| P/BV |
|
0.5305 | 4.82 | -89% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
0.2277 | -22.15 | -101.03% |
|
|
| Ev/S |
|
-0.0748 | 22.56 | -100.33% |
|
|
| Ev/FCF |
|
0.0593 | 68.78 | -99.91% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-32.85 | 4.98 | -760.04% | -97.8 | -66.41% |
| ROE |
|
-91.72 | 9.61 | -1054.29% |
|
|
| ROA |
|
-63.45 | 0.3443 | -18531.27% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-57.33 | -25.17 | 127.77% |
|
|
| ROCE |
|
-59.21 | 15.35 | -485.74% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.9315 | -3.68 | -74.66% | -0.5903 | +57.82% |
| Nеt Debt/Ebitda |
|
1.24 | -3.44 | -135.99% |
|
|
| Debt/Ratio |
|
0.3387 | 0.1985 | 70.63% |
|
|
| Debt/Equity |
|
0 | 1.66 | -100% |
|
|
| Debt/Net Income |
|
-0.5338 | 10.32 | -105.17% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-7.54 | -56.89 | -86.75% | ||
| Growth impulse Ebitda in 5 years |
|
-12.79 | -54.68 | -76.61% | ||
| Growth impulse Net Income in 5 years |
|
3.12 | -58.33 | -105.35% | ||
| Growth impulse FCF in 5 years |
|
-1.66 | -49.48 | -96.65% | ||
| Growth impulse EPS in 5 years |
|
4546.31 | -32.41 | -14127.49% |
IP Score
3.61/10
